FDA – Page 4 – cannabis.co.nz

February 25, 2021analysis, analytics, business, cannabis, CAPA, cbd, cGMPs, compliance, compliant, consumer, cosmetics, CSA, cultivation, Current good manufacturing Practice, device, dietary supplements, dispensary, drug, Edibles & Processing, employee training, equipment design, extraction, facility design, FDA, Federal, food, GMP, GMPs, good manufacturing practice, government, growing, industry, Kathleen May, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, marijuana, market, medical, medicine, Operations, product, Quality, regulation, regulations, regulatory, risk management, safety, schedule I, standard, state, Supply Chain, system, test, Testing, thc, Triskele Quality Solutions, USDA

GMPs & Cannabis Manufacturing

Editor’s Note: While CIJ typically omits the word “marijuana” where possible due to antiquated nomenclature and prejudicial connotations, we understand the legal […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

September 16, 2020administer, analysis, analytics, business, CA, Cali, california, California Department of Public Health, cannabis, CDC, CDPH, compliance, contact, Coronavirus, COVID, COVID-19, cowroker, disease, EEOC, employee, employer, employment, Equal Employment Opportunity Commission, family, FDA, Genetic Information Nondiscrimination Act, government, growing, guidelines, handbook, illness, industry, infected, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, member, Operations, product, Quality, question, regulation, regulations, regulatory, retail, return, rule, safety, spread, state, team, test, Testing, to, trace, tracing, virus, work, workplace

California Employment Laws, COVID-19 & Cannabis: How New Regulations Impact Cannabis Businesses

As employers in the cannabis industry adapt to making their businesses run and thrive in the age of COVID-19, federal, state and […]

September 10, 2020analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, Congress, congressional, controlled substances act, cultivation, dea, department of justice, derived, DOJ, Drug Enforcement Administration, farm, Farming, FDA, FDCA, Federal, food and drug administration, government, growing, hemp, industry, interim, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, National Institute of Standards and Technology, NIST, plant, plants, political, politics, product, Quality, recreational, reg, regulation, regulations, regulatory, retail, rule, safety, schedule, state, test, Testing, thc, THCA

CBD Industry Caught Between Regulators & Law Enforcement

The consumer-facing CBD industry operates in a regulatory gray zone even as it grows in prominence. Illegal to market as an unapproved […]

August 26, 2020action, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, claim, class, compliance, consumer, court, district court, Duane Morris, extraction, farm bill, FDA, Federal, government, growing, hemp, industry, infused, judge, label, law, lawsuit, legal, legalization, legalize, legislation, license, marijuana, market, marketed, marketing, medical, medicine, oil, product, Product Development, Quality, regulation, regulations, regulatory, retail, state, suit, Supply Chain, test, Testing, thc, U.S.

Consumer Class Actions Against CBD Companies Are Hitting a Snag

Over the past year, more and more consumer class actions have been filed against manufacturers and distributors of CBD-infused products. These actions […]

August 19, 20202018, action, analysis, analytics, argument, attorney, business, Business Analysis, california, cannabidiol, cannabis, case, cases, cbd, class, complaint, compliance, Concentrates & Extracts, consumer, cosmetic, court, cultivation, deadline, defendant, deferred, derived, dietary supplement, dismiss, Dispensaries & Retail, dispensary, drug, Edibles & Processing, ent, extraction, farm bill, FDA, FDCA, Federal, federal food drug and cosmetic act, file, florida, food, Goodwin, government, growing, hemp, industry, judge, judgement, jurisdiction, lab, laboratories, laboratory, labs, law, lawsuit, lawyer, legal, legalization, legalize, legislation, license, litigate, litigation, marijuana, market, massachusetts, medical, medicine, motion, pending, plaintiff, product, Product Development, products, prosecutor, pursuant, Quality, regulation, regulations, regulatory, retail, rulemaking, ruling, safety, scheme, state, stayed, sue, suit, test, Testing, thc, vacate

CBD You in Court: Consumer Class Actions Involving Hemp-Derived CBD Products

Consumer demand for products containing cannabidiol (CBD) is on the rise across the country, with industry experts estimating that the market for […]

August 4, 2020cannabidiol, Cannabis Industry & Marijuana Business Briefs, cbd, Dravet syndrome, Epidiolex, Europe Cannabis Industry & Marijuana Business News, FDA, GW Pharmaceuticals, International Marijuana Business News, Lennox-Gastaut syndrome, Medical Cannabis Industry & Recreational Marijuana Business News, tuberous sclerosis complex, U.S. Food and Drug Administration, United States Cannabis Industry & Marijuana Business News

FDA approves GW Pharmaceuticals’ cannabis drug for new indication

CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding […]